HIV Pre-Exposure Prophylaxis (PrEP) purchase patterns and STI occurrence among Israeli men: A cohort analysis
<h4>Background</h4> HIV Pre-exposure prophylaxis (PrEP) is the regular use of antiretroviral medication by people who are not infected with HIV to prevent seroconversion. Israel approved PrEP for continuous use in 2017, and Israeli Health Maintenance Organizations (HMO) offered PrEP with...
Guardado en:
Autores principales: | Daniel Chemtob, Clara Weil, Jordan Hannink Attal, Elias Hawila, Enav Noff Sadeh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d46ff7462faf47819bfe08f06e0995cb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
HIV Pre-Exposure Prophylaxis (PrEP) purchase patterns and STI occurrence among Israeli men: A cohort analysis.
por: Daniel Chemtob, et al.
Publicado: (2021) -
HIV pre-exposure prophylaxis (PrEP)--a quantitative ethics appraisal.
por: Madzouka B Kokolo, et al.
Publicado: (2011) -
HIV seroconversion during pregnancy and the need for pre-exposure prophylaxis (PrEP)
por: Zorrilla CD, et al.
Publicado: (2018) -
Pre-Exposure Prophylaxis (PrEP) in the Prevention of HIV: Strategies, Target Populations and Upcoming Treatments
por: Özdener-Poyraz AE, et al.
Publicado: (2020) -
Barriers to the use of pre-exposure prophylaxis (PrEP) among heterosexual serodiscordant couples in Western Kenya: Stigma and misconceptions
por: Gaelen Stanford-Moore, et al.
Publicado: (2016)